Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-057704

Director sold 3,665 shares at $17.78 ($65,164)

  • Director acquired 10,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Curet Myriam · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-22 Grant or award : show line 1 in the form +10,200 29,440 D
2021-09-22 Sale : show line 2 in the form −3,665 $17.78 $65,164 25,775 D
Open-market sales · 3,665 sh · avg $17.78 · $65,164

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-22 Grant or award : show line 3 in the form Stock Option +20,400 20,400 D
Loading xslF345X03/doc4.xml…